STRUCTURAL AND CONFORMATIONAL REQUIREMENTS FOR HUMAN CALCITONIN ACTIVITY - DESIGN, SYNTHESIS, AND STUDY OF LACTAM-BRIDGED ANALOGS

被引:54
作者
KAPURNIOTU, A [1 ]
TAYLOR, JW [1 ]
机构
[1] RUTGERS STATE UNIV,DEPT CHEM,PISCATAWAY,NJ 08855
关键词
D O I
10.1021/jm00005a011
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The conformational and pharmacological effects of the introduction of conformational constraints in the form of i-(i + 4) lactam-bridges in the potential amphiphilic alpha-helical region (8-21) of human calcitonin (hCT) were studied. The following three cyclic hCT analogues were synthesized: cyclo(17,21)-[Lys(17),Asp(21)]hCT (1), cyclo(17,21)-[Asp(17),Lys(21)]hCT (2) and cyclo(10,14)-[Lys(10),Asp(14)]hCT (3). For their syntheses, solid-phase methodology was used in combination with either-direct side chain to side chain cyclization on the solid support or a segment-condensation strategy. Circular dichroism studies in aqueous buffer, pH 7.0, indicated that the conformational effects were different for each lactam bridge introduced. Significant induction of alpha-helical structure was observed only fdr peptide 3. In contrast, peptide 1 and hCT had similar CD spectra, indicative of mixed disordered and beta-sheet conformations, and peptide 2 had a weaker spectrum consistent with the formation of a more ordered but nonhelical structure. In rat brain receptor binding assays, peptide 2 showed a nearly 80-fold higher potency than hCT or peptides 1 and 3. All three analogues stimulated adenylyl cyclase in the rat kidney membrane at 5-fold lower concentrations than hCT and with similar maximal effects. In vivo hypocalcemic assays, performed in mice by analysis of serum calcium levels 1 h after sc injection, indicated that peptide 2 had similar maximal effects to hCT and was 10-20 times more potent than hCT at doses giving half-maximal effects. In contrast, peptides 1 and 3 were not significantly more potent than hCT. Our findings indicate compatibility of all three lactam bridges and, most probably, also the amphiphilic alpha-helix, with the pharmacological activities of hCT. However, the properties of peptide 2 also suggest that another conformation, possibly a type I beta-turn involving residues 17-20, may play an important role. A multistep mechanism of receptor recognition by hCT that might account for these results is discussed.
引用
收藏
页码:836 / 847
页数:12
相关论文
共 62 条
[11]   CALCITONIN ALTERS BEHAVIOR OF ISOLATED OSTEOCLASTS [J].
CHAMBERS, TJ ;
MAGNUS, CJ .
JOURNAL OF PATHOLOGY, 1982, 136 (01) :27-39
[12]   CYCLIC PARATHYROID-HORMONE RELATED PROTEIN ANTAGONISTS - LYSINE-13 TO ASPARTIC-ACID 17 [I TO (I + 4)] SIDE-CHAIN TO SIDE-CHAIN LACTAMIZATION [J].
CHOREV, M ;
ROUBINI, E ;
MCKEE, RL ;
GIBBONS, SW ;
GOLDMAN, ME ;
CAULFIELD, MP ;
ROSENBLATT, M .
BIOCHEMISTRY, 1991, 30 (24) :5968-5974
[13]  
CHOREV M, 1993, INT J PEPT PROT RES, V42, P342
[14]   EMPIRICAL PREDICTIONS OF PROTEIN CONFORMATION [J].
CHOU, PY ;
FASMAN, GD .
ANNUAL REVIEW OF BIOCHEMISTRY, 1978, 47 :251-276
[15]  
DOI M, 1993, PEPTIDES 1992, P165
[16]  
EPAND RM, 1985, INT J PEPT PROT RES, V25, P105
[17]   BIOLOGICALLY-ACTIVE CALCITONIN ANALOGS WHICH HAVE MINIMAL INTERACTIONS WITH PHOSPHOLIPIDS [J].
EPAND, RM ;
EPAND, RF ;
ORLOWSKI, RC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (01) :203-207
[18]   CONFORMATIONAL FLEXIBILITY AND BIOLOGICAL-ACTIVITY OF SALMON-CALCITONIN [J].
EPAND, RM ;
EPAND, RF ;
ORLOWSKI, RC ;
SEYLER, JK ;
COLESCOTT, RL .
BIOCHEMISTRY, 1986, 25 (08) :1964-1968
[19]   DELETION SEQUENCES OF SALMON-CALCITONIN THAT RETAIN THE ESSENTIAL BIOLOGICAL AND CONFORMATIONAL FEATURES OF THE INTACT MOLECULE [J].
EPAND, RM ;
EPAND, RF ;
STAFFORD, AR ;
ORLOWSKI, RC .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (08) :1595-1598
[20]  
FELIX AM, 1988, INT J PEPT PROT RES, V32, P441